Multiple sclerosis is not directly inherited like some genetic conditions, but it does run in families. The general population has roughly a 0.1% chance of developing MS. If you have a first-degree relative with MS (a parent, sibling, or child), your risk is about seven times higher than average. That’s a meaningful increase, but it still means the vast majority of people with a family connection to MS will never develop it themselves.
How Family History Affects Your Risk
The closer your biological relationship to someone with MS, the more your risk increases. Full siblings face the highest odds, with roughly 8 to 9 times the risk of the general population. Parents and children of someone with MS carry about 6 to 7 times the general risk. Second-degree relatives (aunts, uncles, grandparents, half-siblings) have about twice the baseline risk.
These numbers come from large population studies tracking MS diagnoses across family trees. They hold for both the most common form of MS, relapsing-onset, and the rarer progressive-onset form. But even at 8 or 9 times a 0.1% baseline, the absolute risk remains in the low single digits. A sibling of someone with MS still has a better than 99% chance of not developing it.
What Twin Studies Reveal
Twin research offers the clearest window into how much genetics matter. When one identical twin has MS, the other twin develops it about 25% of the time. For fraternal twins, who share only half their genes like any siblings, that figure drops to about 5%. The gap between those two numbers is powerful evidence that genes play a real role.
The split is even more dramatic in women. Female identical twins show a concordance rate of 34%, roughly ten times higher than female fraternal twins at about 4%. This likely reflects the fact that MS is two to three times more common in women overall, and the genetic contribution appears to be stronger in females.
But here’s the key takeaway: if MS were purely genetic, identical twins would match 100% of the time. The fact that three out of four identical twins of an MS patient never develop the disease tells us that genes alone are not enough. Something else has to be present for the disease to take hold.
Why MS Is Not a Single-Gene Condition
MS does not follow the inheritance pattern of conditions like sickle cell disease or cystic fibrosis, where a single gene mutation causes the disease. Instead, MS is what geneticists call a complex polygenic trait. Researchers have confirmed at least 233 variations across the human genome that each contribute a small amount to MS risk. No single variant is powerful enough on its own to predict whether someone will develop the disease.
The strongest genetic contributor sits in the immune system’s identity-tagging machinery. A gene variant called HLA-DRB1*15:01 has been consistently linked to MS across nearly every population studied. People who carry two copies of this variant produce dramatically higher levels of certain immune signaling proteins, roughly 8 times more of one key protein than people without it. This likely causes the immune system to behave more aggressively against the body’s own nerve insulation, which is the core problem in MS. Still, many people carry this variant and never develop MS, and many people with MS don’t carry it. It raises risk without guaranteeing disease.
Genetic Risk Across Different Populations
Most MS genetic research has focused on people of European descent, but studies are beginning to map how these risk variants behave in other populations. About 76% of known MS risk variants show the same directional effect in Hispanic populations, and about 68% do in African American populations. So there’s considerable overlap, but not a perfect match.
African Americans show larger differences in the frequency of risk-associated gene variants compared to Europeans, which means genetic risk scores built from European data don’t predict MS as accurately in African American individuals. Hispanic populations, by contrast, have risk variant frequencies closer to European populations, and the same risk scoring tools work somewhat better. Research into population-specific genetic risk for MS is still catching up, but the underlying biological pathways, particularly those involving immune cell behavior and inflammation, appear to be shared across groups.
Environmental Factors That Interact With Genes
Genetic susceptibility sets the stage, but environmental exposures often determine whether MS actually develops. Two factors have the strongest evidence behind them: infection with Epstein-Barr virus (EBV) and low vitamin D levels.
EBV, the virus that causes mono, is present in nearly all MS patients. Research suggests that having both EBV infection and the high-risk HLA gene variant creates a combined effect that is stronger than either factor alone. The virus may confuse the immune system in people whose genes already make their immune response more aggressive, pushing it to attack the protective coating around nerves.
Vitamin D appears to play a protective role. MS is more common in countries farther from the equator, where people get less sun exposure and tend to have lower vitamin D levels. Genetic variations in the vitamin D receptor also appear in MS risk profiles, suggesting that some people are biologically less efficient at using whatever vitamin D they do get. The interplay between low vitamin D, certain gene variants, and viral infection paints a picture of MS as a disease that requires multiple triggers lining up at once.
Should Family Members Get Genetic Testing?
There is currently no recommended genetic test for MS risk. Because MS involves hundreds of small-effect gene variants rather than a single identifiable mutation, no test can meaningfully predict whether an individual will develop the disease. The variants associated with MS are common in the general population, which means a positive result would be nearly meaningless for any one person, and a negative result wouldn’t rule MS out.
Genetic testing is not offered for diagnostic, predictive, or prenatal purposes related to MS. If you have a family member with MS and are concerned about your own risk, the most useful conversation is with a neurologist or primary care provider who can discuss recurrence risks in practical terms and address any symptoms you might be experiencing. The hereditary component of MS is real but modest, and for most family members, it translates to a slightly elevated risk that remains quite low in absolute terms.